Status:
COMPLETED
Retro-Auricular Single-Site Endoscopic to Papillary Thyroid Carcinoma
Lead Sponsor:
Sun Yat-sen University
Conditions:
Papillary Thyroid Carcinoma
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The goal of this non randomized control clinical research study is to compare the cosmetic outcomes and efficiacy of retro-auricular single-site endoscopic thyroid lobectomy and central lymph node dis...
Eligibility Criteria
Inclusion
- Age 18-70 years old, no gender restrictions.
- Fine-needle aspiration cytology(FNA) confirmed papillary thyroid carcinoma(PTC).
- Early stage PTC (stage T1N0M0).
- Preoperative ultrasonography showed unilateral glandular lobe malignant tumor and the largest diameter was not more than 2cm, without cervical lymph node metastasis and extensive metastasis.
- Patients undergoing thyroid lobectomy and central lymph node dissection.
- Patients who have signed an approved Informed Consent.
Exclusion
- Patients who do not accept case data collection for various reasons.
- The clinical data unfit this study (at the discretion of the investigator).
- Patients who have undergone neck surgery or radiotherapy before this trail.
- Patients who have uncontrolled hyperthyroidism.
Key Trial Info
Start Date :
March 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05263141
Start Date
March 1 2022
End Date
November 30 2024
Last Update
December 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sun Yat-Sen University Cancer Center
Guangzhou, Guangdong, China